Abbott Receives FDA Approval for Epic Max Tissue Valve to Treat Aortic Valve Disease
The new valve is designed to preserve and facilitate future patient options for lifetime management of their heart valve disease
Source: dicardiology.com
Stay updated with breaking news from Epic Max. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The new valve is designed to preserve and facilitate future patient options for lifetime management of their heart valve disease
Abbott (NYSE:ABT) announced today that the FDA approved its Epic Max stented tissue valve for treating aortic regurgitation or stenosis.
Abbott (NYSE:ABT) announced today that the FDA approved its Epic Max stented tissue valve for treating aortic regurgitation or stenosis.